Skip to content
Biodatica
Start free

JOSLIN DIABETES CENTER

BOSTON, MA

OncologyGrant-only
Compare Sign in to watch

What changed

Study registered, no phase assigned: EVOC - EVs in Obesity and Cardiometabolic Disease

4w agoTrial registeredJun 17, 2026Source filing (opens the source filing in a new tab)

Momentum

82no change

Momentum 82 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

15,632 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R01 · $535k · non-dilutive

    Jan 2, 2024

    UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DOMINGUEZ-BENDALA, JUAN · NIDDK · award ends Dec 31, 2028 · BMP signaling and regenerative plasticity: Correlating dynamic scRNAseq and real-time anatomical remodeling in T1D pancreatic slices

    NIH RePORTER · NIH RePORTER 11249564 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Apr 19, 2023

    CHF, ADHF, Control · RECRUITING · sponsor: Massachusetts General Hospital · Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)

    ClinicalTrials.gov · NCT06169540 (opens the source filing in a new tab)

  3. Grant

    U01 · $882k · non-dilutive

    Sep 20, 2022

    JOSLIN DIABETES CENTER · PI KULKARNI, ROHIT N. · NIDDK · award ends Jun 30, 2027 · Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk

    NIH RePORTER · NIH RePORTER 11144314 (opens the source filing in a new tab)

  4. Trial

    Study registered

    Feb 2, 2019

    Cardiovascular Diseases · RECRUITING · sponsor: Massachusetts General Hospital · EVOC - EVs in Obesity and Cardiometabolic Disease

    ClinicalTrials.gov · NCT06408961 (opens the source filing in a new tab)

  5. Trial

    Study registered

    Aug 17, 2016

    Acute Congestive Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Normal Ejection Fraction · ACTIVE_NOT_RECRUITING · sponsor: Massachusetts General Hospital · Circulating RNAs in Acute Congestive Heart Failure

    ClinicalTrials.gov · NCT03345446 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources